You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明生物(02269.HK):提升美國馬薩諸塞州基地產能
阿思達克 01-10 14:22
藥明生物(02269.HK)今日股價上揚,最新報27.6元升4.7%。藥明生物近日公布,公司將擴大美國馬薩諸塞州伍斯特基地(生物藥原液十一廠,MFG11)產能至3.6萬升。 為了滿足全球客戶日益增長的合同生產服務需求,伍斯特基地將在原計劃2.4萬升產能的基礎上新增1.2萬升商業化原液產能。伍斯特基地面積達18.95萬平方英尺,近期已完成耐候建設,預計將在2025年正式營運,並在2026年投入GMP生產。目前藥明生物美國共有400名員工,伍斯特基地全面營運後將新增200個工作崗位。 藥明生物首席執行官陳智勝表示,伍斯特基地是藥明生物全球生產網絡的關鍵一環,此次新增商業化產能也彰顯了公司根據市場和客戶需求不斷鞏固能力和規模的承諾。(wl/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account